23 May 2013
Keywords: s-p, caelyx, gets, new, indication, eu, schering-plough
Article | 20 January 2003
Schering-Plough has been granted approval in the European Union forCaelyx (liposomal doxorubicin) for the treatment of patients with
advanced breast ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 January 2003
27 January 2003
22 May 2013
© 2013 thepharmaletter.com